Revolutionize Your Lab with a Cutting-Edge Bioprocess Platform to Drive Quality and Efficiency
Tackling Rising Costs and Reducing Time to Market
Having broken global sales records in the past, biopharmaceutical companies are now seeing consistent industry growth and have been valued at billions of dollars in 20181. A study from 2016 has also found that the average cost of new drug and biologics development is now in excess of $2.5 billion and growing at a rate of more than 8% per year2.
With the right solution organizations can simplify their lab-based working, while ensuring the highest level of compliance with regulatory requirements, ultimately savings costs and reducing time to market – but it can be hard to know where to start.
In this eBook, we explain how you can harmonize bioprocess execution, increase efficiency, and ensure seamless cross-departmental collaboration across cell line development, process development and analytical development all within a secure, accessible and powerful end-to-end solution for Bioprocess workflows.
To learn more, download your copy of the eBook below!
- According to the FDA, invalid or unreliable data is a sign of poor control of equipment and operations
- Unnecessarily repeating work is an expensive business
- By integrating inventory and barcoding with experimental execution, error-prone and time-consuming manual data entry is reduced